Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Congenital myopathies

H H Goebel1

  • 1Department of Neuropathology, Mainz University Medical Center, Germany.

Seminars in Pediatric Neurology
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Congenital myopathies (CM) are rare genetic neuromuscular disorders. While new types are identified, pinpointing the specific genes responsible for most CM remains challenging due to their rarity and classification issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog.

Molecular genetics and metabolism·2016
Same author

Protein aggregation in inclusion body myositis, a sporadic form among protein aggregate myopathies, and in myofibrillar myopathies--a comparative study.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2011
Same author

Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.

Neuropediatrics·2010
Same author

CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL.

Neurology·2010
Same author

Macrophagic myofasciitis plus (distinct types of muscular dystrophy).

Neuropediatrics·2010
Same author

Consequences of mutations within the C terminus of the FHL1 gene.

Neurology·2009
Same journal

Concussion in contact sport: risks, detection, & prevention.

Seminars in pediatric neurology·2026
Same journal

A multidisciplinary, symptom-targeted approach to rehabilitation in pediatric concussion.

Seminars in pediatric neurology·2026
Same journal

Pediatric concussion beyond sports: Falls, play, and everyday activities.

Seminars in pediatric neurology·2026
Same journal

Return-to-school protocols in pediatric concussion care.

Seminars in pediatric neurology·2026
Same journal

Improving concussion recognition in youth sports: the role of parents, coaches, and community education.

Seminars in pediatric neurology·2026
Same journal

Concussion management, rehabilitation, and societal impact.

Seminars in pediatric neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Congenital myopathies (CM) represent a spectrum of hereditary neuromuscular disorders.
  • Characterized by minimal or no progression, CM are traditionally diagnosed using morphological techniques like enzyme histochemistry and electron microscopy.
  • The classification of CM has expanded to include approximately 40 distinct conditions.

Purpose of the Study:

  • To review the current nosologic and genetic landscape of congenital myopathies.
  • To highlight advances in diagnostic techniques and the challenges in molecular genetic identification of CM genes.

Main Methods:

  • Morphological techniques (enzyme histochemistry, electron microscopy) for initial diagnosis.
  • Immunohistochemical methods to identify protein abnormalities in muscle fibers.

Related Experiment Videos

  • Review of existing literature on gene localization for CM.

    • Main Results:

    • The number of identified CM conditions has grown to around 40.
    • Immunohistochemistry has aided in recognizing protein abnormalities in specific CM.
    • Genetic localization has lagged, with genes identified only for central core disease, nemaline myopathy, and myotubular myopathy.

    Conclusions:

    • Despite advances in morphological and immunohistochemical diagnostics, the molecular genetic understanding of congenital myopathies is limited.
    • The rarity and nosographic complexity of CM contribute to the slow progress in gene discovery.
    • Further research is needed to overcome these challenges and advance the molecular genetics of CM.